 | Up a level |
Abdul Aziz, Al-Fattah Yahaya * and Kanwal, Khalid * and Lim, Hui Xuan * and Poh, Chit Laa * (2023) Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern. Viruses, 15 (3). p. 624. ISSN 1999-4915
Lim, Hui Xuan * and Lim, Jian Hua * and Jazayeri, S. D. * and Poppema, Sibrandes * and Poh, Chit Laa * (2020) Development of multi-epitope peptide-based vaccines against SARS-CoV-2. Biomedical Journal, 44 (1). pp. 18-30. ISSN 2319-4170
Lim, Hui Xuan * and Lim, Jian Hua * and Poh, Chit Laa * (2021) Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine. Medical Microbiology and Immunology, 210 (1). pp. 1-11. ISSN 0300-8584
Lim, Hui Xuan * and Masomian, Malihe * and Kumar, Asqwin Uthaya and MacAry, Paul A. and Poh, Chit Laa * (2022) Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting. International Journal of Molecular Sciences, 23 (8). p. 4341. ISSN 1422-0067
Lim, Hui Xuan * and Masita, Arip and Abdul Aziz, Al-Fattah Yahaya * and Jazayeri, S. D. * and Poppema, Sibrandes * and Poh, Chit Laa * (2021) Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials. Frontiers in Bioscience-Landmark, 26 (11). pp. 1286-1304. ISSN 2768-6698
Lee, Michelle Felicia * and Voon, Guan Zhong * and Lim, Hui Xuan * and Chua, Mun Lok * and Poh, Chit Laa * (2022) Innate and adaptive immune evasion by dengue virus. Frontiers in Cellular and Infection Microbiology, 12. ISSN 2235-2988
Lim, Hui Xuan * and Poh, Chit Laa * (2019) Insights into innate and adaptive immune responses in vaccine development against EV-A71. Therapeutic Advances in Vaccines and Immunotherapy, 7. ISSN 2515-1355
Lalani, Salima and Tan, Soon Hao and Tan, Kuan Onn * and Lim, Hui Xuan * and Ong, Kien Chai and Wong, Kum Thong and Poh, Chit Laa * (2021) Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice. Life Sciences, 287. p. 120097. ISSN 0024-3205
Jazayeri, S. D. * and Lim, Hui Xuan * and Shameli, Kamyar and Yeap, S. K. and Poh, Chit Laa * (2021) Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases. Frontiers in Pharmacology, 12. ISSN 1663-9812
Kanwal, Khalid * and Lim, Hui Xuan * and Ayaz, Anwar * and Tan, Soon Hao and Hwang, Jung Shan * and Ong, Seng Kai * and Poh, Chit Laa * (2024) Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice. AAPS PharmSciTech, 25 (3). ISSN 1530-9932
Poh, Chit Laa * and Kanwal, Khalid * and Lim, Hui Xuan * (2023) Probiotics: A solution to the prevention of antimicrobial resistance. In: Antibiotics - Therapeutic Spectrum and Limitations. Developments in Microbiology . Academic Press, London, pp. 596-609. ISBN 9780323953887
Lim, Hui Xuan * and Kim, Tae Sung and Poh, Chit Laa * (2020) Understanding the differentiation, expansion, recruitment and suppressive activities of myeloid-derived suppressor cells in cancers. International Journal of Molecular Sciences, 21 (10). p. 3599. ISSN 1422-0067
Heng, Wen Tzuen * and Lim, Hui Xuan * and Tan, Kuan Onn * and Poh, Chit Laa * (2023) Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus. Pharmaceutical Research, 40 (8). pp. 1999-2025. ISSN 0724-8741
